↓ Skip to main content

Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2005
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
28 Mendeley
Title
Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
Published in
Cancer Immunology, Immunotherapy, September 2005
DOI 10.1007/s00262-005-0085-7
Pubmed ID
Authors

N. Ramnath, D. Tan, Q. Li, B. L. Hylander, P. Bogner, L. Ryes, S. Ferrone

Abstract

To characterize HLA class I antigen expression in non-small cell lung cancer (NSCLC) lesions, and to assess the clinical significance of these molecules' downregulation.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 4%
Unknown 27 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 18%
Student > Bachelor 5 18%
Other 4 14%
Lecturer 2 7%
Student > Master 2 7%
Other 5 18%
Unknown 5 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 18%
Medicine and Dentistry 5 18%
Biochemistry, Genetics and Molecular Biology 4 14%
Pharmacology, Toxicology and Pharmaceutical Science 3 11%
Immunology and Microbiology 2 7%
Other 4 14%
Unknown 5 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2016.
All research outputs
#7,438,092
of 22,738,543 outputs
Outputs from Cancer Immunology, Immunotherapy
#1,037
of 2,892 outputs
Outputs of similar age
#20,464
of 59,048 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#22
of 32 outputs
Altmetric has tracked 22,738,543 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,892 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,048 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.